In particular, the patients analyzed by Rosti [21] showed at least one EC harboring the JAK2 mutation, but not all the ECs analyzed carried out it, suggesting that the endothelium of MPN patients may be composed by a mix of wild-type and JAK2 mutated ECs. This evidence concerns the gene JAK2 and myeloproliferative disorder.